Nacuity Pharmaceuticals
Pre-clinicalAdvancing a promising treatment for retinitis pigmentosa
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $17M
About
Advancing a promising treatment for retinitis pigmentosa
Small Molecules
Funding History
2Total raised:$17M
Grant$2MMay 15, 2021
Series A$15MOct 15, 2020